CINC

CinCor Pharma, Inc. Common Stock
CINC

Overview Fund Activity
Delisted

CINC was delisted on the 23rd of February, 2023.

Back to rankings

53 hedge funds and large institutions have $520M invested in CinCor Pharma, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
0.84%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
%
% of All Funds
0.08%
New
53
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SI
1
Sofinnova Investments
California
$97.8M
2
5VM
2
5AM Venture Management
California
$76.1M
3
GA
3
General Atlantic
New York
$72.4M
4
PA
4
Perceptive Advisors
New York
$40.7M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$36.6M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
MLICM
51
Metropolitan Life Insurance Company (MetLife)
New York
$16.6K 948 +948 New
AIP
52
Ameritas Investment Partners
Nebraska
$16K 900 +900 New
TRCT
53
Tower Research Capital (TRC)
New York
$8K 447 +447 New
CFGS
54
Concourse Financial Group Securities
Alabama
– – – –
1 2
3